플라즈맵

405000· KOSDAQ· Health Care· Health Care Equipment & Services

₩3,280-1.35%

2026-09-18

Financials

Valuation Metrics

플라즈맵's Market Cap is ₩176B. At end of 2025 it was ₩312B. Ranked #2367 of 2,421 in KR market (top 98%), #1593 of 1,640 on KOSDAQ (top 97%), #94 of 96 in Health Care Equipment & Services (top 98%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	17.63B KRW	KR#2,367/2,421 Sec#94/96
Revenue	12.02B KRW	KR#2,260/2,421 Sec#79/96
Net Income	-7.73B KRW	KR—/2,421 Sec—/96
Total Assets	19.23B KRW	KR#2,380/2,421 Sec#96/96
Net Assets	1.31B KRW	KR#2,397/2,421 Sec#96/96
Employees	91	KR#1,713/2,421 Sec#66/96
Value
P/B	13.45x	KR#2,380/2,421 Sec#95/96
P/S	1.47x	KR#1,624/2,421 Sec#44/96
FCF Yield	-27.24%	KR—/2,421 Sec—/96
Profitability
ROA	-40.18%	KR#2,348/2,421 Sec#91/96
Op. Margin	-58.97%	KR#2,251/2,421 Sec#79/96
Revenue Growth	113.82%	KR#71/2,421 Sec#7/96
Financial Health
Debt Ratio	1367.44%	KR#2,384/2,421 Sec#96/96
Total Debt	15.71B KRW	KR#1,481/2,421 Sec#44/96
FCF	-4.80B KRW	KR#1,488/2,421 Sec#50/96
Cash	2.52B KRW	KR#2,196/2,421 Sec#90/96
Current Ratio	0.92x	KR#1,820/2,421 Sec#82/96
Performance
1Y Return	-61.73%	KR#2,225/2,421 Sec#86/96
1M Return	-16.33%	KR#2,267/2,421 Sec#87/96
From 52W High	-65.11%	KR#2,036/2,421 Sec#73/96
1Y MDD	-65.27%	KR#1,763/2,421 Sec#61/96
Trading
Volume	10,241 shares	KR#1,905/2,421 Sec#78/96
Trading Value	33.5M KRW	KR#1,986/2,421 Sec#81/96
Foreign Own.	8.48%	KR#536/2,421 Sec#15/96
Per Share
EPS	-1,438 KRW	KR—/2,421 Sec—/96
BPS	244 KRW	KR#2,413/2,421 Sec#96/96

Company Info

CEO 이윤철(단독 대표이사)

Employees 91

Founded 2015

HQ 대전광역시 유성구, KR

Website plasmapp.com/

동사는 2015년 KAIST 물리학과 실험실 창업으로 설립된 바이오 플라즈마 딥테크 기업이며, 2022년 코스닥시장에 상장했음. 플라즈마 원천기술 기반 저온멸균 솔루션, 임플란트 재생활성 솔루션, 치주·근관치료기 등 3대 제품군을 보유하고 있음. 2021년 비미국 회사 최초 FDA 인증으로 미국 진출 기반을 확보하였고, 2025년 ACTILINK가 세계 최초 인증을 받아 관련 시장 선도를 추진하고 있음. 플라즈맵는 2015년에 설립되었으며 대전광역시 유성구에 본사를 두고 있습니다.